SP-1018R (Supratek)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameSP-1018R (Supratek)

Drug Alias NameSP-1018R

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSupratek Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSupratek Pharma

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

ATC CodeN/A